NCT04240834View on ClinicalTrials.gov

Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary Intervention

PHASE4RecruitingINTERVENTIONAL
Enrollment

1,220

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Acute Coronary SyndromeInterventional Cardiology
Interventions
DRUG

Aspirin

Comparison of 12 months of ticagrelor and low-dose aspirin versus 12 months of standard dual anti-platelet therapy (DAPT)

DRUG

Ticagrelor

Comparison of 12 months of ticagrelor and low-dose aspirin versus 12 months of standard dual anti-platelet therapy (DAPT)

Trial Locations (1)

Unknown

RECRUITING

Fuwai Hospital, Beijing

All Listed Sponsors
lead

Fu Wai Hospital, Beijing, China

OTHER